Future unrelated medical costs need to be considered in cost effectiveness analysis

van Baal, Pieter and Morton, Alec and Meltzer, David and Brouwer, Werner (2019) Future unrelated medical costs need to be considered in cost effectiveness analysis. European Journal of Health Economics, 20 (1). pp. 1-5. ISSN 1618-7601 (https://doi.org/10.1007/s10198-018-0976-0)

[thumbnail of van-Baal-etal-EJHE-2018-Future-unrelated-medical-costs-need-to-be-considered-in-cost-effectiveness-analysis]
Preview
 Text. Filename: van_Baal_etal_EJHE_2018_Future_unrelated_medical_costs_need_to_be_considered_in_cost_effectiveness_analysis.pdf
Accepted Author Manuscript
Download (510kB)| Preview

Abstract

New medical technologies that prolong life result in additional health care use in life years gained. Some of these costs in life years gained are considered to be related to the intervention while other costs are considered unrelated. Here, we argue that ignoring these so-called future medical costs in cost effectiveness analysis is contrary to common sense, results in lost health and fails to inform decision makers for whom cost effectiveness is supposed to serve.

ORCID iDs

van Baal, Pieter, Morton, Alec ORCID logoORCID: https://orcid.org/0000-0003-3803-8517, Meltzer, David and Brouwer, Werner;
CORE (COnnecting REpositories)